D-1045-2018 Class II Terminated

Recalled by PharMEDium Services, LLC — Dayton, NJ

FDA drug recall D-1045-2018 was initiated by PharMEDium Services, LLC on Jul 24, 2018 and is designated Class II. Reason for recall: CGMP deviations: Product was released while a hood certification discrepancy was being investigated. The recall status is terminated (terminated Dec 10, 2018). Affected quantity: 575 Syringes.

Recall Details

Product Type
Drugs
Report Date
Aug 15, 2018
Initiation Date
Jul 24, 2018
Termination Date
Dec 10, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
575 Syringes

Product Description

10 mg/mL Rocuronium Bromide (Preservative Free) 5 mL BD Syringe, PharMEDium Services, LLC.

Reason for Recall

CGMP deviations: Product was released while a hood certification discrepancy was being investigated.

Distribution Pattern

Product was distributed throughout the United States

Code Information

Lot 181780003D

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1045-2018
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 25, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.